Is ktra hard to borrow?

**Kintara Therapeutics (KTRA) is currently easy to borrow**, as indicated by the low short borrow fee rates and the high number of shares available for shorting. This makes it relatively accessible for investors to take a short position, which could be reflected in the high trading volume and the availability of shares for shorting.

1. **Short Borrow Fee Rates**: The short borrow fee rates for KTRA are currently low, which means that lenders are willing to lend shares at a lower cost. This can make it more attractive for investors to borrow shares and sell them short.
2. **Short Volume and Float**: The number of short shares available (4,743,521) and the short interest ratio (0.38) are high, indicating a large supply of shares available for shorting. This suggests that there is ample liquidity in the market for KTRA shares, which can make it easier for investors to borrow shares and execute short trades.
3. **Market Sentiment**: The sentiment around KTRA does not indicate a build-up of short sellers that could trigger a short squeeze. The recent decline in short interest and the lack of bullish catalysts suggest that market participants are not taking aggressive short positions.

In conclusion, Kintara Therapeutics (KTRA) is not hard to borrow, and the current market conditions suggest that it is relatively easy for investors to take a short position in the stock. However, it's important to note that the ease of borrowing can also depend on the overall market conditions and the specific lending practices of brokers or institutions.